oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Ciprofloxacin Kabi 400 mg/200 ml roztwór do infuzji

It was found that Ciprofloxacin Kabi cartons contained bottles labeled Glucosum 5% Fresenius with the same batch number, indicating mix-up of infusion products and risk of administering the wrong medicine. Potential effects: lack of efficacy, infusion-related complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Ciprofloxacin Kabi 400 mg/200 ml roztwór do infuzji
Risk Level
Critical
Manufacturer
Fresenius Kabi Deutschland GmbH
Batch Number
15QFD570
EAN Code
05909990737178
Recall Date
10.09.2021
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from batch 15QFD570; healthcare facilities and pharmacies should immediately segregate this batch and return it to the wholesaler or the marketing authorisation holder.

Actions Taken

Withdrawal from the market throughout the country of batch 15QFD570 of the medicinal product Ciprofloxacin Kabi 400 mg/200 ml solution for infusion, granting the decision immediate enforceability, and...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: It was found that Ciprofloxacin Kabi cartons contained bottles labeled Glucosum 5% Fresenius with the same batch number, indicating mix-up of infusion products and risk of administering the wrong medicine. Potential effects: lack of efficacy, infusion-related complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 15QFD570

Related

Other Recalled Products